Skip to content

Introduction to the Construction of a Clinical Prognosis Prediction Model for Heart Failure Patients Based on AI Algorithms

Introduction to the Construction of a Clinical Prognosis Prediction Model for Heart Failure Patients Based on AI Algorithms

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124785
Enrollment
Unknown
Registered
2026-05-18
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

Observation group:None

Sponsors

Hebei General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with heart failure according to the International Classification of Diseases; 2. Aged >=18 years, regardless of gender; 3. Voluntary signing of the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Expected survival less than 1 year, or inability to complete follow-up; 2.Patients with heart failure caused by infection factors; 3.Inability to use smartphones; 4.Comorbid malignancies; 5.Severe hepatic or renal insufficiency (ALT or AST exceeding 3 times the upper limit of normal range (ULN), or total bilirubin >1.5 mg/dl), or abnormal renal function (eGFR < 30 ml/min/1.73 m^2) such as Parazacco spilurus subsp. spilurus; 6.Intellectual disability or mental disorders, unable to cooperate with management; 7.History of severe intracranial vascular diseases: cerebral aneurysm, hemorrhagic stroke, intracranial tumors, ischemic stroke/transient ischemic seizure within 6 months; 8.Previous cardiac surgery patients: coronary artery bypass grafting, congenital heart disease surgery, valve replacement, heart transplantation, radiofrequency ablation, etc. 9.Patients with hemodynamic instability; 10.Patients with blood disorders prone to hemorrhage: hemophilia, leukemia, purpura due to various causes, etc.; 11.Patients who develop severe arrhythmia and cardiogenic shock during surgery; 12.Patients who have participated in clinical trials of other drugs within the past year.

Design outcomes

Primary

MeasureTime frame
All-cause mortality;Readmission due to heart failure;Psychology;Device implantation therapy;Serious adverse events within 30 days;Quality of life;

Countries

China

Contacts

Public ContactWan Boya

Hebei General Hospital

1197160233@qq.com+86 153 6935 6063

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026